{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-004461","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2026-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.590504+00:00","generated_at":"2026-05-16T06:05:27.738659+00:00","sec_items":["7.01","9.01"],"event_type":"dividend","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Tevogen Bio board to evaluate potential one-time special cash dividend after unspecified milestones","bullets":["Board intends to evaluate a special cash dividend contingent on future financial milestones (revenue, earnings targets).","No dividend has been declared; any declaration subject to financial performance, solvency laws, and board approval.","No assurance can be given on timing, amount, or whether a dividend will occur at all.","Company plans to provide further updates as appropriate under disclosure requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-004461","json":"https://secwatch.observer/filing/0001493152-26-004461.json","markdown":"https://secwatch.observer/filing/0001493152-26-004461.md","text":"https://secwatch.observer/filing/0001493152-26-004461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226004461/0001493152-26-004461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000149315226004461/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:05:27.738659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}